Combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
AssigneeOleg I. Epshtein
InventorsOleg Iliich Epshtein, Svetlana Alexandrovna Sergeeva, Liudmila Fyodorovna Dolgovyh, Vladmir Ivanovich Petrov
Life of this patent
Estimating the term…
Abstract
The present application provides a pharmaceutical composition for administration to a patient suffering from at least one symptom of a cardiovascular condition, the composition comprising a) an activated-potentiated form of an antibody to angiotensin II AT1 receptor, and b) an activated-potentiated form of an antibody to endothelial NO-synthase.
Claims82
A combination pharmaceutical composition for administration to a patient suffering from at least one symptom of a cardiovascular condition, said composition comprising a) an activated-potentiated form of an antibody to angiotensin II AT1 receptor, and b) an activated-potentiated form of an antibody to endothelial NO-synthase.
A method of treating a patient suffering from a reduced overall quality of life associated with at least one symptom of a cardiovascular condition, said method comprising administering to said patient substantially at the same time a) an activated-potentiated form of an antibody to angiotensin II AT1 receptor, and b) an activated-potentiated form of an antibody to endothelial NO-synthase, thereby said administration improves said overall quality of life of said patient.
A method of treating a patient suffering from chronic heart failure, said method comprising administering to said patient a combination of a) an activated-potentiated form of an antibody to angiotensin II AT1 receptor, and b) an activated-potentiated form of an antibody to endothelial NO-synthase.
A method of treating a patient suffering from asthenia and/or vegetative-vascular dystonia, said method comprising administering to said patient a combination of a) an activated-potentiated form of an antibody to angiotensin II AT1 receptor, and b) an activated-potentiated form of an antibody to endothelial NO-synthase.
Dependencies are inferred from the claim text.